Albemarle Corporation (ALB) Stock Forecast
Data as of Oct 31, 2026Basic Materials · Current price $90.19 (-3.31%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 6, 2026 | Peter Osterland | Truist Financial | $210.00 | +132.8% |
| Feb 23, 2026 | Andres Castanos-Mollor | Berenberg Bank | $153.00 | +69.6% |
| Feb 13, 2026 | Vincent Andrews | Morgan Stanley | $170.00 | +88.5% |
| Jan 21, 2026 | Arun Viswanathan | RBC Capital | $200.00 | +121.8% |
| Jan 21, 2026 | Peter Osterland | Truist Financial | $205.00 | +127.3% |
| Jan 12, 2026 | David Begleiter | Deutsche Bank | $185.00 | +105.1% |
| Jan 12, 2026 | Joshua Spector | UBS | $205.00 | +127.3% |
| Jan 5, 2026 | Laurence Alexander | Jefferies | $167.00 | +85.2% |
| Dec 17, 2025 | Peter Osterland | Truist Financial | $125.00 | +38.6% |
| Dec 16, 2025 | Vincent Andrews | Morgan Stanley | $147.00 | +63.0% |
| Dec 3, 2025 | David Begleiter | Deutsche Bank | $125.00 | +38.6% |
| Nov 19, 2025 | Joel Jackson | BMO Capital | $136.00 | +50.8% |
| Aug 29, 2025 | Ben Kallo | Robert W. Baird | $68.00 | -24.6% |
| Aug 26, 2025 | Joshua Spector | UBS | $89.00 | -1.3% |
| Jul 29, 2025 | Ben Kallo | Robert W. Baird | $60.00 | -33.5% |
| Jul 15, 2025 | John Roberts | Mizuho Securities | $76.00 | -15.7% |
| Jul 11, 2025 | Joshua Spector | UBS | $57.00 | -36.8% |
| May 14, 2025 | Charles Neivert | Piper Sandler | $68.00 | -24.6% |
| Feb 18, 2025 | Vincent Andrews | Morgan Stanley | $68.00 | -24.6% |
| Nov 13, 2024 | Andres Castanos-Mollor | Berenberg Bank | $102.00 | +13.1% |
Top Analysts Covering ALB
ALB vs Sector & Market
| Metric | ALB | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.29 | 2.34 | 2.41 |
| Analyst Count | 34 | 7 | 19 |
| Target Upside | +85.3% | +577.2% | +21.5% |
| P/E Ratio | -43.08 | -9.08 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.47B | $5.86B | $6.53B | 13 |
| 2027-03-31 | $1.45B | $1.57B | $1.78B | 4 |
| 2027-06-30 | $1.67B | $1.82B | $2.05B | 6 |
| 2027-09-30 | $1.55B | $1.68B | $1.90B | 4 |
| 2027-12-31 | $1.47B | $1.60B | $1.81B | 7 |
| 2028-03-31 | $1.70B | $1.85B | $2.09B | 3 |
| 2028-06-30 | $1.83B | $1.99B | $2.25B | 5 |
| 2028-09-30 | $1.63B | $1.77B | $2.00B | 3 |
| 2028-12-31 | $1.56B | $1.69B | $1.91B | 6 |
| 2029-12-31 | $6.74B | $7.50B | $8.58B | 7 |
| 2030-12-31 | $7.89B | $8.79B | $10.04B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.07 | $8.44 | $13.31 | 10 |
| 2027-03-31 | $1.68 | $1.87 | $2.19 | 3 |
| 2027-06-30 | $2.14 | $2.38 | $2.78 | 3 |
| 2027-09-30 | $2.02 | $2.26 | $2.64 | 4 |
| 2027-12-31 | $1.94 | $2.16 | $2.53 | 3 |
| 2028-03-31 | $3.51 | $3.91 | $4.57 | 4 |
| 2028-06-30 | $3.85 | $4.29 | $5.01 | 4 |
| 2028-09-30 | $3.24 | $3.61 | $4.21 | 6 |
| 2028-12-31 | $3.04 | $3.39 | $3.96 | 4 |
| 2029-12-31 | $8.89 | $10.25 | $12.16 | 1 |
| 2030-12-31 | $12.36 | $14.25 | $16.90 | 1 |
Frequently Asked Questions
What is the analyst consensus for ALB?
The consensus among 34 analysts covering Albemarle Corporation (ALB) is Buy with an average price target of $202.63.
What is the highest price target for ALB?
The highest price target for ALB is $320.00, set by Jonathan Petersen at Jefferies on 2022-06-20.
What is the lowest price target for ALB?
The lowest price target for ALB is $57.00, set by Joshua Spector at UBS on 2025-07-11.
How many analysts cover ALB?
34 analysts have issued ratings for Albemarle Corporation in the past 12 months.
Is ALB a buy or sell right now?
Based on 34 analyst ratings, ALB has a consensus rating of Buy (2.29/5) with a +85.3% upside to the consensus target of $202.63.
What are the earnings estimates for ALB?
Analysts estimate ALB will report EPS of $8.44 for the period ending 2026-12-31, with revenue estimated at $5.86B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.